August 14, 2013

Walgreens posted an 8% boost in July sales as comp-store sales also enjoyed an increase for the month.

August 13, 2013

According to a new report released by Express Scripts, the stress associated with providing unpaid care for a sick or disabled adult can create additional detrimental effects on the caregiver's health, leading to a 29% greater use of anti-anxiety medications compared with non-caregivers.

August 8, 2013

By now, even a quick look at drug companies' product pipelines and patient demographics should make it clear that specialty drugs are where it's at.

August 5, 2013

Express Scripts and Walgreens last week announced the launch of Smart90 Walgreens, a new option for Express Scripts clients interested in 90-day prescription drug programs and to help drive lower costs. The program is expected to improve medication adherence by both providing a cost value to the patient while maintaining what has more and more become a crucial patient-pharmacist face-to-face encounter.

What a difference a year makes. Far removed from its squabbles over reimubursement, the two companies partner on a new program that reinforces the value that retail pharmacy provides and the innovative ways that retail and mail can work together to create solutions that help get patients on, and keep them on, their medications.

August 1, 2013

Express Scripts and Walgreens announced the launch of Smart90 Walgreens, a new option for Express Scripts clients interested in 90-day prescription drug programs that helps drive lower costs.

July 12, 2013

The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.

July 1, 2013

Though Walgreens reported an earnings gain of 85 cents per share, that fell short of Wall Street expectations of 91 cents per share. Subsequently, Walgreens' stock dropped from $48.05 before the earnings release to $44.17 at week's end.

But that's a story for day traders. Outside of the numbers, Walgreens outlined a three-point plan to boost front-end performance going forward. Meanwhile, several industry trends across pharmacy is helping to drive business higher behind the bench. So what happens if Walgreens not only continues its earnings growth trajectory, but actually beat Wall Street expectations next time?

June 24, 2013

Rite Aid reported its third consecutive profitable quarter Thursday, with profits of nearly $90 million, following the introduction of the largest expansion of its Wellness+ loyalty card program, dubbed Wellness65+, and days before the promotion of COO Ken Martindale to president of the company.

The 4,615-store drug chain has been on a roll lately, continuing to benefit from the switch from branded to generic drugs and the retention of last year's dispute between Walgreens and Express Scripts.

June 20, 2013

Rite Aid posted its third consecutive profitable quarter Thursday morning as it launched the largest extension to date to its loyalty card program and continued growing the latest iteration of its new store format.

June 3, 2013

The state attorney general of New York is urging health insurers to let patients buy specialty drugs through retail pharmacies instead of having to use mail-order.

May 31, 2013

Anthem Blue Cross patients with HIV can continue receiving their drugs through community specialty pharmacies under a settlement of a lawsuit filed against the healthcare company by an advocacy organization.

May 21, 2013

Spending on specialty drugs is likely to increase by 67% over the next couple of years, according to a new study by pharmacy benefit manager Express Scripts.

May 1, 2013

The year appears to be off to a good start, and CVS Caremark executives were optimistic Wednesday morning as the company pulled in a “strong” first quarter and narrowed its 2013 guidance to reflect higher-than-expected performance.

April 23, 2013

Unnecessary spending related to medications totaled nearly half a trillion dollars last year, and much of that was in the poorest states in the country, according to pharmacy benefit manager Express Scripts.

April 12, 2013

Rite Aid reported a $123.1 million profit for fourth quarter 2013 and $118.1 million for the fiscal year - its first profitable year since 2007 - amid greater generic drug penetration and retention of at least three-quarters of the customers who switched over to the chain during the dispute between Walgreens and pharmacy benefit manager Express Scripts, among other factors.

In other words, the factors that helped fuel the nearly $62 million profit the company reported in third quarter 2013 have continued to hold, which means the 4,623-store chain has put itself on track for strong future growth, which will no doubt be helped along by the debt refinancing the company finished in February.

April 11, 2013

Rite Aid's profits grew in the fourth quarter and fiscal year 2013 amid stronger front-end sales and prescription count, the retail pharmacy chain said.

April 8, 2013

A joint conference by the National Association of Specialty Pharmacy and the Association of Managed Care Pharmacy attracted hundreds of leaders from across the specialty pharmacy industry.

March 19, 2013

Even as Walgreens expands its operation globally through strategic partnerships with both Alliance Boots and now AmerisourceBergen, the pharmacy operator continues to create some retail pop in the U.S. market.

March 8, 2013

While the country's spending on specialty drugs increased by 18.4% in 2012, spending on traditional drugs fell for the first time in 20 years, according to a report by Express Scripts.

March 7, 2013

Employers that use multiple cost-management programs have a 50% lower specialty drug trend than those that don't use them, according to a new study by pharmacy benefit manager Express Scripts.

March 5, 2013

Walgreens' February sales fell short of analyst projections due to a sharper impact from generic drug introductions.

February 19, 2013

Anthem Blue Cross will indefinitely suspend a policy that would require many specialty pharmacy patients in California, most of them HIV patients, to receive their drugs via mail order in order to receive coverage for them, drawing criticism from patients and retail pharmacies.

February 6, 2013

CVS Caremark executives expressed optimism Wednesday morning as the company posted record fourth-quarter results, raised its 2013 guidance and continues to work to leverage its distinctive business model to help people on their path to better health amid a rapidly changing healthcare environment.

February 5, 2013

Cardinal Health posted $25.2 billion in revenue for its 2013 second quarter, down 7%. The company's non-GAAP diluted earnings per share was up 15% to $0.93.